M

Moderna

Develops mRNA-based medicines for health

Director Market Access

Business & StrategyConfirmed live in the last 24 hours
Full-timeLondon, UKNo salary listed

About the Job

Requirements

  • A tertiary degree in Economics, Sciences, or Pharmacy and/or a postgraduate degree in Health Economics or Business.
  • Experience in the biotechnology or pharmaceutical industries in a UK Market Access role; vaccine experience is a strong advantage.
  • Extensive business acumen, analytical skills, and experience working with local and global internal business partners, especially Medical, Regulatory, Marketing, Clinical, Legal, Communications, and Government Affairs, to provide insight into key economic and reimbursement issues for products.
  • Excellent understanding of the UK healthcare ecosystem, health technology assessment processes, and pricing dynamics for vaccines and therapeutics.
  • Experience working with and/or established relationships with the Department of Health and Social Care and Health Security Agency.
  • Ability to communicate effectively with diverse audiences through oral presentations, written proposals, reports, and correspondence.
  • Ability to manage competing demands within tight deadlines and adapt to ambiguity and change in an evolving environment.
  • Demonstrated project management experience managing complex projects and third parties.
  • Sound business judgment and analytical skills, operating to high ethical standards.
  • Ability to demonstrate Moderna’s values of being Bold, Curious, Relentless, and Collaborative, and to build a personal and company brand reflecting its mRNA platform technology.
  • The role may require an enhanced pre-employment check.

Responsibilities

  • Serve as the UK Pricing, Reimbursement & Market Access lead, establishing and developing the country strategy and agenda in collaboration with local and global teams.
  • Partner with Regulatory, Medical, Communications, External Affairs, and Marketing leads to build an integrated Market Access approach and support Moderna’s broader UK strategy.
  • Lead and develop the Health Economic Outcomes Research Manager through dotted-line management, supporting preparation of clinical and economic evidence for reimbursement and pricing submissions.
  • Guide development of access and outcomes research studies addressing evidence needs and strengthening Moderna’s value proposition.
  • Lead pricing and reimbursement negotiations with the UK Health Security Agency, applying knowledge of the UK healthcare ecosystem, health technology assessment processes, and pricing dynamics across vaccines and therapeutics.
  • Develop business cases and proposals to secure internal approvals for access, pricing, and reimbursement strategies.
  • Lead Access engagement with UK experts and stakeholders, building relationships within government, Public Health, and relevant organizations.
  • Represent customer and stakeholder insights within Moderna so external perspectives inform strategy, evidence development, and execution.
  • Identify and support opportunities for Moderna to demonstrate leadership at external forums and events covering vaccine development, access, pricing, immunization systems, and deployment.
  • Partner with external stakeholders to establish shared public policy goals, identify solutions through research and dialogue, and engage policymakers, advocacy organizations, business groups, and other stakeholders in support of Moderna’s strategy and business objectives.
  • Build and strengthen relationships with the Department of Health and Social Care and UK Health Security Agency, using established relationships and knowledge of the UK healthcare environment.
  • Work with local and global partners across Medical, Regulatory, Marketing, Clinical, Legal, Communications, and Government Affairs, providing insight into economic and reimbursement issues for Moderna products.
  • Manage complex projects and third parties while balancing competing priorities, tight deadlines, ambiguity, and a rapidly evolving external environment.
  • Apply business judgment, analytical capability, and high ethical standards to strategic and executional decisions.
  • Communicate complex Market Access, economic, and reimbursement topics to diverse audiences through presentations, proposals, reports, and correspondence.
  • Shape the UK environment and market, working at both strategic and executional levels as Moderna advances its portfolio.
  • Demonstrate Moderna’s values and build a personal and company brand reflecting the innovative potential of its mRNA platform technology.
  • Explore the use of Generative AI tools to accelerate insight generation, synthesize market and stakeholder information, and improve the efficiency and quality of Market Access work within appropriate governance frameworks.

Desired Qualifications

  • Vaccines experience is a strong advantage.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs